Reminder: DOT expanding drug testing to include opioids on Jan. 1, 2018
Tags : DOT Compliance
The U.S. Department of Transportation (DOT) recently posted an additional notice in anticipation of the upcoming Jan. 1, 2018 effective date.
The notice is available here.
As a reminder, the DOT is expanding their existing drug testing panel – which consists of marijuana, cocaine amphetamines, phencyclidine (PCP) and opiates – to include testing for four semi-synthetic opioids. The four semi-synthetic opioids are hydrocodone, hydromorphone, oxymorphone and oxycodone. Some common names for these semi-synthetic opioids include OxyContin®, Percodan®, Percocet®, Vicodin®, Lortab®, Norco®, Dilaudid® and Exalgo®.
Companies that are covered by the DOT should amend their drug testing programs accordingly prior to Jan. 1, 2018.
Source: Transportation.gov, 12/11/2017
We cannot express enough how much we have enjoyed working with BIG! It has really benefitted our processing and ease of doing business!
I enjoy collaborating with BIG, and know that if I have to reach out with a question/concern, a positive attitude with a willingness to find resolve is on the other side of an email or a phone call.
You have been the most professional and most helpful business partner that I have ever been associated with — always there to assist us and with rapid turnaround times.
I am confident whenever we add a product with your company that I will have a good experience.
We have received superior service and we know this is what you and your team strive for. We are grateful for the dedication, level of professionalism and effort shown.